-
WCLC Interview | Dr. Baohui Han: Discussion and Prospects of Hot Topics in Targeted Therapy of Lung Cancer
The 2023 World Conference on Lung Cancer (WCLC), held from September 9th to 12th at the Singapore, provided a platform for oncology experts to delve into cutting-edge developments. The “Oncology Frontier” team reports on-the-spot international cutting-edge developments and witnesses the progress of China’s anti-cancer cause on the international stage. Renowned oncologist Dr. Baohui Han, from…
-
2023 WCLC | Dr. Caicun Zhou Discusses Latest Results on EGFR exon20ins Mutation
The World Conference on Lung Cancer (WCLC), a significant academic exchange event in the global lung cancer field, was successfully held in Singapore from September 9 to 12, 2023. The conference revealed many important research findings, bringing about a new era of treatment in clinical practice. Among them, the EGFR Exon20 insertion mutation (EGFR exon20ins)…
-
WCLC Interview | Dr. Clarissa Baldotto: Treatment strategies after failure of immunotherapy for lung cancer
The 2023 World Conference of Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), was grandly held in Singapore from September 9th to 12th. At the WCLC conference, Dr. Clarissa Baldotto, President of the Brazilian Group of Thoracic Oncology, was invited by “Oncology frontier” to talk about the treatment…
-
WCLC Interview | Professor Richard Sullivan Discusses Global Cancer Medical Technology and Policy Developments
Editor’s Note: The World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), took place from September 9 to 12 in Singapore.…
-
Application of ADC in First-Line Treatment of NSCLC and Interpretation of Results from the EVOKE-02 Study
The 24th World Conference on Lung Cancer (WCLC) was held from September 9 to 12, 2023, in Singapore, organized by the International Association for the Study of Lung Cancer (IASLC). During the oral presentation session on September 10, the EVOKE-02 study, exploring the first-line treatment of advanced non-small cell lung cancer (NSCLC) with the combination…
-
WCLC Live Interview | Dr. Baohui Han and Dr. Roy Herbst Interpret FAVOUR Study, Discuss the Treatment of Advanced Lung Cancer with EGFR ex20ins Mutation
The 24th World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), took place from September 9th to 12th, 2023, in Singapore.…
-
WCLC Interview | Dr. CaiCun Zhou Interprets Important Researches and Future Trends in the Field of ADC
Editor’s Note: The 2023 World Conference on Lung Cancer (WCLC) was held in Singapore from September 9 to 12. The “Oncology Frontier” team delved into the frontlines, capturing international advancements,…
-
Polatuzumab Vedotin Enhances Treatment Efficacy in Previously Untreated DLBCL: Insights from the Asia Subpopulation of the POLARIX Trial
In an enlightening development within the realm of oncology, a recent study titled “Polatuzumab Vedotin in Previously Untreated DLBCL: An Asia Subpopulation Analysis from the Phase 3 POLARIX Trial” has…
Connecting Medical Expertise through Media